US equities
|
MU
$1,088.72
▲+4.13%
SNDK
$1,728.15
▲+4.08%
NVDA
$237.28
▼-0.82%
AMD
$645.55
▼-0.60%
SPCX
$167.44
▼-2.61%
INTC
$113.15
▲+0.58%
TSLA
$376.38
▼-1.13%
AAPL
$336.75
▲+0.94%
MU
$1,088.72
▲+4.13%
SNDK
$1,728.15
▲+4.08%
NVDA
$237.28
▼-0.82%
AMD
$645.55
▼-0.60%
SPCX
$167.44
▼-2.61%
INTC
$113.15
▲+0.58%
TSLA
$376.38
▼-1.13%
AAPL
$336.75
▲+0.94%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by RenovoRx, Inc
RenovoRx Highlights Promising Pre-Clinical Data Abstract: TAMP™ Therapy Platform Offers Potential to Improve Localized and Targeted Drug Delivery
February 13, 2025
From
RenovoRx, Inc
Via
Business Wire
Tickers
RNXT